Drug Trial Radar · NCT06260163
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
112
Actual
Start
Jan 19, 2024
Primary completion
Feb 10, 2027
Study completion Apr 28, 2027
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Feb 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of guselkumab in pediatric participants with moderately to severely active ulcerative colitis at the end of maintenance therapy among participants who were induction responders.
Conditions
- Colitis, Ulcerative
Interventions
Guselkumab SubcutaneousDrug
Guselkumab will be administered subcutaneously.
Guselkumab IntravenousDrug
Guselkumab will be administered intravenously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with Clinical Remission at Week 56Time frame: Week 56
Locations
61 sites in 13 countries. Site status is shown where the registry gives one.
Children's Hospital Oakland
Oakland, California
Riley Hospital for Children
Indianapolis, Indiana
NYU Langone Health
Lake Success, New York
The Kids Research Institute Australia on behalf of the Centre for Child Health Research
Nedlands, Australia
Mater Hospital Brisbane Inflammatory Bowel Diseases
South Brisbane, Australia
The Children's Hospital at Westmead
Westmead, Australia
CHU Charleroi Chimay
Charleroi, Belgium
UZ Gent
Ghent, Belgium
UZ Brussel
Jette, Belgium
UZ Leuven
Leuven, Belgium
Capital Center For Children's health Capital Medical University
Beijing, China
Peking University Third Hospital
Beijing, China
Changzhou No 2 Peoples Hospital
Changzhou, China
The Childrens Hospital Zhejiang University School Of Medicine
Hangzhou, China
Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, China
Ruijin Hospital Shanghai Jiao Tong University
Shanghai, China
Shengjing Hospital Of China Medical University
Shenyang, China
Henan Children's Hospital, Zhengzhou Children's Hospital
Zhengzhou, China
Aarhus Universitetshospital
Aarhus N, Denmark
Hvidovre Hospital
Hvidovre, Denmark
Hospices Civils de Lyon - Groupement Hospitalier Est - Hopital Femme Mere Enfant
Bron, France
Hopital Francois Mitterand
Dijon, France
CHRU Lille
Lille, France
APHP Hopital Robert Debre
Paris, France
CHU Toulouse
Toulouse, France
ASST Papa Giovanni XXIII Bergamo
Bergamo, Italy
Azienda USL di Bologna - Ospedale Maggiore
Bologna, Italy
AOU Meyer
Florence, Italy
Ospedale S. Spirito, Azienda Sanitaria Pescara
Pescara, Italy
AOU Policlinico Umberto I
Roma, Italy
IRCCS Ospedale Pediatrico Bambino Gesu
Roma, Italy
Casa Sollievo della Sofferenza
San Giovanni Rotondo, Italy
IRCCS Materno Infantile Burlo Garofolo
Trieste, Italy
Tokyo Metropolitan Children's Medical Center
Fuchū, Japan
Kanazawa University Hospital
Kanazawa, Japan
Kobe University Hospital
Kobe, Japan
Japanese Red Cross Kumamoto Hospital
Kumamoto, Japan
Shinshu University Hospital
Matsumoto, Japan
Saga University Hospital
Saga, Japan
National Center for Child Health and Development
Setagaya Ku, Japan
Showing 40 of 61 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.